Morgan Stanley
Real-time prices from Yahoo Finance's public feed. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Latest news
All MS news ›Morgan Stanley Stock Ahead of Q3 Earnings: Buy, Hold or Sell?
The Globe and Mail Morgan Stanley Stock Ahead of Q3 Earnings: Buy, Hold or Sell? Morgan StanleyMS is set to announce third-quarter 2026 earnings on Oct. 14 before market open. The company’s upcoming financial results and management…
Chubb (CB) Receives a Hold from Morgan Stanley
Morgan Stanley analyst Bob Huang maintained a Hold rating on Chubb today and set a price target of $350.00. According to TipRanks, Huang is an analyst with an average return of -1.3% and a 50.52% success rate. Huang covers the Financial…
Morgan Stanley (MS) Laps the Stock Market: Here's Why
In the latest trading session, Morgan Stanley (MS) closed at $190.02, marking a +1.38% move from the previous day. This change outpaced the S&P 500's 0.6% gain on the day. Meanwhile, the Dow experienced a rise of 0.83%, and the…
Morgan Stanley Issues a Hold Rating on Amgen (AMGN)
In a report released today, Terence Flynn from Morgan Stanley assigned a Hold rating to Amgen, with a price target of $362.00. Flynn covers the Healthcare sector, focusing on stocks such as BioNTech SE, Merck & Company, and Amgen.…
Merck & Company (MRK) Gets a Buy from Morgan Stanley
In a report released today, Terence Flynn from Morgan Stanley assigned a Buy rating to Merck & Company, with a price target of $179.00. Flynn covers the Healthcare sector, focusing on stocks such as BioNTech SE, Merck & Company, and Amgen.…
Bristol-Myers Squibb (BMY) Gets a Sell from Morgan Stanley
Morgan Stanley analyst Terence Flynn assigned a Sell rating to Bristol-Myers Squibb today and set a price target of $40.00. According to TipRanks, Flynn is a 5-star analyst with an average return of 9.1% and a 58.50% success rate. Flynn…
Morgan Stanley Keeps Their Buy Rating on Nasdaq (NDAQ)
Morgan Stanley analyst Michael Cyprys maintained a Buy rating on Nasdaq today and set a price target of $118.00. According to TipRanks, Cyprys is a 3-star analyst with an average return of 1.4% and a 49.70% success rate. Cyprys covers the…
Nasdaq price target lowered to $118 from $120 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on Nasdaq (NDAQ) to $118 from $120 and keeps an Overweight rating on the shares as part of an ear... Nasdaq price target lowered to $118 from $120 at Morgan Stanley Morgan Stanley lowered the…
Morgan Stanley backs up report that Apple cut iPhone 18 Pro component orders by at least 15%
CNBC Morgan Stanley backs up report that Apple cut iPhone 18 Pro component orders by at least 15%
Morgan Stanley Sticks to Their Hold Rating for Willis Towers Watson (WTW)
Morgan Stanley analyst Bob Huang maintained a Hold rating on Willis Towers Watson today and set a price target of $310.00. Huang covers the Financial sector, focusing on stocks such as Progressive, Aon, and Arthur J Gallagher & Co.…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
-
tradingview.com1,591
-
marketscreener.com1,179
-
marketbeat.com824
-
theglobeandmail.com771
-
seekingalpha.com725
Measured across the 4Opinions news index. Headline tone is a simple word-based reading of the latest 120 headlines, not a forecast.